Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
DE
EN
Books
Journals
Events
Topic Page
Marketing
Log in
Learn more about individual access
Request company access
Electric Powertrains and Energy Systems 2025 | 26 + 27 March 2025

19th International MTZ Congress on Future Powertrains

Take this opportunity to attend the conference. Experts from the automotive industry, energy providers, and grid operators will meet up with representatives from politics and science to discuss important topics for this sector.
EXTENDED SEARCH
Log in
Top
Published in:

2017 | OriginalPaper | Chapter

1. SPIONs as Nano-Theranostics Agents

Authors : Atefeh Zarepour, Ali Zarrabi, Arezoo Khosravi

Published in: SPIONs as Nano-Theranostics Agents

Publisher: Springer Singapore

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

With a rapid growth in different fields of science and technology, hopes for further improvement of human life were developed; among them is progress in medicine, which is directly linked with human health. A lot of researches have been conducted specifically for improving the current modalities of diagnosis and treatment of various diseases, especially cancer. Among them is the application of nanotechnology in the field of medicine, which is known as nanomedicine that can develop new therapeutic and diagnostic concepts in all areas of medicine. Nano-theranostics, which is based on the fusion of therapeutic and diagnostic technologies by using nanoparticles, is one of the newest approaches in this field and finally leads to individualized medicine. Magnetic nanoparticle with properties such as good biocompatibility and the ability of surface engineering could be considered as a candidate for theranostic application; briefly it not only could act as a carrier for drugs in drug delivery systems but also could act as therapeutic agent in hyperthermia. Moreover, it could be used as a contrast agent in magnetic resonance imaging (MRI) or could carry imaging agent on its surface. The ability of surface modification makes it possible to transmit engineered nanoparticles to the target organs and reduce side effects of drugs on the other organs; although in this situation external magnetic field could be used for targeting either. These features made us to study the ability of magnetic nanoparticle as a nanotheranostic agent in detail. In summary, in this context we try to introduce magnetic nanoparticle, different approaches that are be used for its synthesis, its applications in the field of treatment and diagnostic and finally its usage as a nanotheranostic agent.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now
Footnotes
1
MNPs.
 
2
MRI.
 
3
SPIONs.
 
4
MCLs.
 
5
CTCs.
 
6
NMR.
 
7
MS.
 
8
PEG.
 
9
FITC.
 
10
EPR.
 
11
PLA.
 
12
PGA.
 
13
PVA.
 
14
PLGA.
 
15
PNIPAAM.
 
16
PVCL.
 
17
siRNA.
 
18
PTT.
 
19
NIR.
 
20
PTA.
 
21
AMF.
 
22
PDT.
 
23
ROS.
 
24
SDT.
 
25
HPG.
 
26
HSA.
 
27
GO.
 
28
PEI.
 
29
FA.
 
30
rGO.
 
31
PA.
 
32
FGF.
 
Literature
1.
Z. Dai, Advances in Nanotheranostics I: Design and Fabrication of Theranosic Nanoparticles (Springer, Berlin, 2015)
2.
K.Y. Choi, G. Liu, S. Lee, X. Chen, Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale 4, 330–342 (2012)CrossRef
3.
Y. Zhou, X. Liang, Z. Dai, Porphyrin-loaded nanoparticles for cancer theranostics. Nanoscale 8, 12394–12405 (2016)CrossRef
4.
Q. Chen, H. Ke, Z. Dai, Z. Liu, Nanoscale theranostics for physical stimulus-responsive cancer therapies. Biomaterials 73, 214–230 (2015)CrossRef
5.
K. Greish, Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Cancer Nanotechnol. Method. Protoc. 624, 25–37 (2010)CrossRef
6.
X. Wu, Y. Gao, C.-M. Dong, Polymer/gold hybrid nanoparticles: from synthesis to cancer theranostic applications. RSC Advances 5, 13787–13796 (2015)CrossRef
7.
D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, R. Langer, Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751–760 (2007)CrossRef
8.
S.K. Sahoo, V. Labhasetwar, Nanotech approaches to drug delivery and imaging. Drug Discovery Today 8, 1112–1120 (2003)CrossRef
9.
J.T. Cole, N.B. Holland, Multifunctional nanoparticles for use in theranostic applications. Drug Deliv. Trans. Res. 5, 295–309 (2015)CrossRef
10.
B. Semete, L. Booysen, Y. Lemmer, L. Kalombo, L. Katata, J. Verschoor, H.S. Swai, In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomed. Nanotechnol. Biol. Med. 6, 662–671 (2010)CrossRef
11.
H. Markides, M. Rotherham, A. El Haj, Biocompatibility and toxicity of magnetic nanoparticles in regenerative medicine. J. Nanomater. 2012, 13 (2012)CrossRef
12.
M. Mahmoudi, A. Simchi, M. Imani, M.A. Shokrgozar, A.S. Milani, U.O. Häfeli, P. Stroeve, A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids Surf. B 75, 300–309 (2010)CrossRef
13.
S. Parveen, R. Misra, S.K. Sahoo, Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed. Nanotechnol. Biol. Med. 8, 147–166 (2012)CrossRef
14.
A. Kroll, M.H. Pillukat, D. Hahn, J. Schnekenburger, Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur. J. Pharm. Biopharm. 72, 370–377 (2009)CrossRef
15.
S.S. Kelkar, T.M. Reineke, Theranostics: combining imaging and therapy. Biocon. Chem. 22, 1879–1903 (2011)CrossRef
16.
J. Wang, Y. Gao, Y. Hou, F. Zhao, F. Pu, X. Liu, Z. Wu, Y. Fan, Evaluation on cartilage morphology after intra-articular injection of titanium dioxide nanoparticles in rats. J. Nanomater. 2012, 1–11 (2012)
17.
S. Neethirajan, D.S. Jayas, Nanotechnology for the food and bioprocessing industries. Food Bioprocess Technol. 4, 39–47 (2011)CrossRef
18.
Q. Huang, H. Yu, Q. Ru, Bioavailability and delivery of nutraceuticals using nanotechnology. J. Food Sci. 75, R50–R57 (2010)CrossRef
19.
V. Sanna, N. Pala, M. Sechi, Targeted therapy using nanotechnology: focus on cancer. Int. J. Nanomed. 9, 467–483 (2014)
20.
T.L. Doane, C. Burda, The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem. Soc. Rev. 41, 2885–2911 (2012)CrossRef
21.
B.Y. Kim, J.T. Rutka, W.C. Chan, Nanomedicine. N. Engl. J. Med. 363, 2434–2443 (2010)CrossRef
22.
Y. Gao, J. Xie, H. Chen, S. Gu, R. Zhao, J. Shao, L. Jia, Nanotechnology-based intelligent drug design for cancer metastasis treatment. Biotechnol. Adv. 32, 761–777 (2014)CrossRef
23.
M.J. Sailor, J.H. Park, Hybrid nanoparticles for detection and treatment of cancer. Adv. Mater. 24, 3779–3802 (2012)CrossRef
24.
J.V. Jokerst, S.S. Gambhir, Molecular imaging with theranostic nanoparticles. Acc. Chem. Res. 44, 1050–1060 (2011)CrossRef
25.
B. Fadeel, A.E. Garcia-Bennett, Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv. Drug Deliv. Rev. 62, 362–374 (2010)CrossRef
26.
R. Singh, J.W. Lillard, Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 86, 215–223 (2009)CrossRef
27.
C.P. McCoy, C. Brady, J.F. Cowley, S.M. McGlinchey, N. McGoldrick, D.J. Kinnear, G.P. Andrews, D.S. Jones, Triggered drug delivery from biomaterials. Expert Opin. Drug Deliv. 7, 605–616 (2010)CrossRef
28.
P. Rai, S. Mallidi, X. Zheng, R. Rahmanzadeh, Y. Mir, S. Elrington, A. Khurshid, T. Hasan, Development and applications of photo-triggered theranostic agents. Adv. Drug Deliv. Rev. 62, 1094–1124 (2010)CrossRef
29.
K.H. Martin, P.A. Dayton, Current status and prospects for microbubbles in ultrasound theranostics. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 5, 329–345 (2013)CrossRef
30.
R.R. Ragheb, D. Kim, A. Bandyopadhyay, H. Chahboune, B. Bulutoglu, H. Ezaldein, J.M. Criscione, T.M. Fahmy, Induced clustered nanoconfinement of superparamagnetic iron oxide in biodegradable nanoparticles enhances transverse relaxivity for targeted theranostics. Magn. Reson. Med. 70, 1748–1760 (2013)CrossRef
31.
D. Maity, S.-G. Choo, J. Yi, J. Ding, J.M. Xue, Synthesis of magnetite nanoparticles via a solvent-free thermal decomposition route. J. Magn. Magn. Mater. 321, 1256–1259 (2009)CrossRef
32.
S. Shen, S. Wang, R. Zheng, X. Zhu, X. Jiang, D. Fu, W. Yang, Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation. Biomaterials 39, 67–74 (2015)CrossRef
33.
J. Wan, W. Cai, X. Meng, E. Liu, Monodisperse water-soluble magnetite nanoparticles prepared by polyol process for high-performance magnetic resonance imaging. Chem. Commun. 47, 5004–5006 (2007)CrossRef
34.
D. Ho, X. Sun, S. Sun, Monodisperse magnetic nanoparticles for theranostic applications. Acc. Chem. Res. 44, 875–882 (2011)CrossRef
35.
A.J. Cole, V.C. Yang, A.E. David, Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol. 29, 323–332 (2011)CrossRef
36.
A.H. Lu, E.E.L. Salabas, F. Schüth, Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. 46, 1222–1244 (2007)CrossRef
37.
M. Faraji, Y. Yamini, M. Rezaee, Magnetic nanoparticles: synthesis, stabilization, functionalization, characterization, and applications. J. Iran. Chem. Soc. 7, 1–37 (2010)CrossRef
38.
C. Okoli, Development of protein-functionalized magnetic iron oxide nanoparticles: potential application in water treatment, Doctoral thesis, 2012
39.
D. Caruntu, G. Caruntu, C.J. O’Connor, Magnetic properties of variable-sized Fe3O4 nanoparticles synthesized from non-aqueous homogeneous solutions of polyols. J. Phys. D Appl. Phys. 40, 5801–5810 (2007)CrossRef
40.
A.K. Gupta, M. Gupta, Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995–4021 (2005)CrossRef
41.
S. Sun, H. Zeng, Size-controlled synthesis of magnetite nanoparticles. J. Am. Chem. Soc. 124, 8204–8205 (2002)CrossRef
42.
R. Hao, R. Xing, Z. Xu, Y. Hou, S. Gao, S. Sun, Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles. Adv. Mater. 22, 2729–2742 (2010)CrossRef
43.
P. Tartaj, M. del Puerto Morales, S. Veintemillas-Verdaguer, T. González-Carreño, C.J. Serna, The preparation of magnetic nanoparticles for applications in biomedicine. J. Phys. D Appl. Phys. 36, R182–R198 (2003)CrossRef
44.
J. Sun, S. Zhou, P. Hou, Y. Yang, J. Weng, X. Li, M. Li, Synthesis and characterization of biocompatible Fe3O4 nanoparticles. J. Biomed. Mater. Res., Part A 80, 333–341 (2007)CrossRef
45.
Z. Liu, Y. Liu, K. Yao, Z. Ding, J. Tao, X. Wang, Synthesis and magnetic properties of Fe3O4 nanoparticles. J. Mater. Synth. Process. 10, 83–87 (2002)CrossRef
46.
E. Bertolucci, A.M.R. Galletti, C. Antonetti, F. Piccinelli, M. Marracci, B. Tellini, C. Visone, Chemical and magnetic properties characterization of magnetic nanoparticles, in Instrumentation and Measurement Technology Conference (I2MTC), IEEE International (2015), pp. 1492–1496
47.
V. Dolgovskiy, V. Lebedev, S. Colombo, A. Weis, B. Michen, L. Ackermann-Hirschi, A. Petri-Fink, A quantitative study of particle size effects in the magnetorelaxometry of magnetic nanoparticles using atomic magnetometry. J. Magn. Magn. Mater. 379, 137–150 (2015)CrossRef
48.
K.C.-F. Leung, S. Xuan, Y.J. Wang, From micro to nano magnetic spheres: size-controllable synthesis. Multilayer Coat. Biomed. Appl. 13, 15 (2016)
49.
P.I. Soares, F. Lochte, C. Echeverria, L.C. Pereira, J.T. Coutinho, I.M. Ferreira, C.M. Novo, Thermal and magnetic properties of iron oxide colloids: influence of surfactants. Nanotechnology 26, 425704 (2015)CrossRef
50.
K.L. Aillon, Y. Xie, N. El-Gendy, C.J. Berkland, M.L. Forrest, Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv. Drug Deliv. Rev. 61, 457–466 (2009)CrossRef
51.
C.C. Berry, S. Wells, S. Charles, A.S. Curtis, Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 24, 4551–4557 (2003)CrossRef
52.
A. Verma, F. Stellacci, Effect of surface properties on nanoparticle–cell interactions. Small 6, 12–21 (2010)CrossRef
53.
J. Huang, L. Bu, J. Xie, K. Chen, Z. Cheng, X. Li, X. Chen, Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano 4, 7151–7160 (2010)CrossRef
54.
D. Stanicki, L. Vander Elst, R.N. Muller, S. Laurent, Synthesis and processing of magnetic nanoparticles. Curr. Opin. Chem. Eng. 8, 7–14 (2015)
55.
C. Corot, P. Robert, J.-M. Idée, M. Port, Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 58, 1471–1504 (2006)CrossRef
56.
L.H. Reddy, J.L. Arias, J. Nicolas, P. Couvreur, Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem. Rev. 112, 5818–5878 (2012)CrossRef
57.
X. Li, W. Liu, L. Sun, K.E. Aifantis, B. Yu, Y. Fan, Q. Feng, F. Cui, F. Watari, Effects of physicochemical properties of nanomaterials on their toxicity. J. Biomed. Mater. Res., Part A 103, 2499–2507 (2015)CrossRef
58.
K. Xiao, Y. Li, J. Luo, J.S. Lee, W. Xiao, A.M. Gonik, R.G. Agarwal, K.S. Lam, The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 32, 3435–3446 (2011)CrossRef
59.
M. Kim, J. Jung, J. Lee, K. Na, S. Park, J. Hyun, Amphiphilic comblike polymers enhance the colloidal stability of Fe3O4 nanoparticles. Colloids Surf., B 76, 236–240 (2010)CrossRef
60.
M. Szekeres, I.Y. Tóth, E. Illés, A. Hajdú, I. Zupkó, K. Farkas, G. Oszlánczi, L. Tiszlavicz, E. Tombácz, Chemical and colloidal stability of carboxylated core-shell magnetite nanoparticles designed for biomedical applications. Int. J. Mol. Sci. 14, 14550–14574 (2013)CrossRef
61.
S. Ghosh, W. Jiang, J.D. McClements, B. Xing, Colloidal stability of magnetic iron oxide nanoparticles: influence of natural organic matter and synthetic polyelectrolytes. Langmuir 27, 8036–8043 (2011)CrossRef
62.
D. Singh, J.M. McMillan, X.-M. Liu, H.M. Vishwasrao, A.V. Kabanov, M. Sokolsky-Papkov, H.E. Gendelman, Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues. Nanomedicine 9, 469–485 (2014)CrossRef
63.
S. Laurent, D. Forge, M. Port, A. Roch, C. Robic, L. Van der Elst, R.N. Muller, Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108, 2064–2110 (2008)CrossRef
64.
S. Mornet, J. Portier, E. Duguet, A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran. J. Magn. Magn. Mater. 293, 127–134 (2005)CrossRef
65.
L. LaConte, N. Nitin, G. Bao, Magnetic nanoparticle probes. Mater. Today 8, 32–38 (2005)CrossRef
66.
A.A. Ismail, Synthesis and characterization of Y2O3/Fe2O3/TiO2 nanoparticles by sol–gel method. Appl. Catal. B 58, 115–121 (2005)CrossRef
67.
Z. Dai, F. Meiser, H. Möhwald, Nanoengineering of iron oxide and iron oxide/silica hollow spheres by sequential layering combined with a sol–gel process. J. Colloid Interface Sci. 288, 298–300 (2005)CrossRef
68.
A.S. Teja, P.-Y. Koh, Synthesis, properties, and applications of magnetic iron oxide nanoparticles. Prog. Cryst. Growth Charact. Mater. 55, 22–45 (2009)CrossRef
69.
A. Roca, M. Morales, K. O’Grady, C. Serna, Structural and magnetic properties of uniform magnetite nanoparticles prepared by high temperature decomposition of organic precursors. Nanotechnology 17, 2783 (2006)CrossRef
70.
Z. Xu, C. Shen, Y. Hou, H. Gao, S. Sun, Oleylamine as both reducing agent and stabilizer in a facile synthesis of magnetite nanoparticles. Chem. Mater. 21, 1778–1780 (2009)CrossRef
71.
P. Tartaj, M.P. Morales, S. Veintemillas-Verdaguer, T. Gonzalez-Carreño, C.J. Serna, Synthesis, properties and biomedical applications of magnetic nanoparticles. Handbook Magn. Mater. 16, 403–482 (2006)CrossRef
72.
W. Cai, J. Wan, Facile synthesis of superparamagnetic magnetite nanoparticles in liquid polyols. J. Colloid Interface Sci. 305, 366–370 (2007)CrossRef
73.
J. Merikhi, H.-O. Jungk, C. Feldmann, Sub-micrometer CoAl2O4 pigment particles—synthesis and preparation of coatings. J. Mater. Chem. 10, 1311–1314 (2000)CrossRef
74.
S.-J. Park, S. Kim, S. Lee, Z.G. Khim, K. Char, T. Hyeon, Synthesis and magnetic studies of uniform iron nanorods and nanospheres. J. Am. Chem. Soc. 122, 8581–8582 (2000)CrossRef
75.
R.A. Mukh-Qasem, A. Gedanken, Sonochemical synthesis of stable hydrosol of Fe3O4 nanoparticles. J. Colloid Interface Sci. 284, 489–494 (2005)CrossRef
76.
E.H. Kim, H.S. Lee, B.K. Kwak, B.-K. Kim, Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent. J. Magn. Magn. Mater. 289, 328–330 (2005)CrossRef
77.
W. Wu, Q. He, C. Jiang, Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res. Lett. 3, 397–415 (2008)CrossRef
78.
Y.-H. Zheng, Y. Cheng, F. Bao, Y.-S. Wang, Synthesis and magnetic properties of Fe3O4 nanoparticles. Mater. Res. Bull. 41, 525–529 (2006)CrossRef
79.
X. Wang, J. Zhuang, Q. Peng, Y. Li, A general strategy for nanocrystal synthesis. Nature 437, 121–124 (2005)CrossRef
80.
H. Cai, X. An, J. Cui, J. Li, S. Wen, K. Li, M. Shen, L. Zheng, G. Zhang, X. Shi, Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications. ACS Appl. Mater. Interfaces 5, 1722–1731 (2013)CrossRef
81.
B.K. Paul, S.P. Moulik, Uses and applications of microemulsions. Curr. Sci. Bangalore 80, 990–1001 (2001)
82.
M. Darbandi, F. Stromberg, J. Landers, N. Reckers, B. Sanyal, W. Keune, H. Wende, Nanoscale size effect on surface spin canting in iron oxide nanoparticles synthesized by the microemulsion method. J. Phys. D Appl. Phys. 45, 195001 (2012)CrossRef
83.
S. Ghorbanzadeh-Mashkani, P. Tajer-Mohammad-Ghazvini, A. Nozad-Golikand, R. Kasra-Kermanshahi, M.-R. Davarpanah, Synthesis of sterile and pyrogen free biogenic magnetic nanoparticles: biotechnological potential of magnetotactic bacteria for production of nanomaterials, in Proceedings of World Academy of Science, Engineering and Technology, World Academy of Science, Engineering and Technology (WASET), vol. 74 (2013), pp. 194–198
84.
C. Prasad, K. Sreenivasulu, S. Gangadhara, P. Venkateswarlu, A facile green synthesis of spherical Fe3O4 magnetic nanoparticles and their effect on degradation of methylene blue in aqueous solution. J. Mol. Liq. 221, 993–998 (2016)CrossRef
85.
M. Mahdavi, F. Namvar, M.B. Ahmad, R. Mohamad, Green biosynthesis and characterization of magnetic iron oxide (Fe3O4) nanoparticles using seaweed (Sargassum muticum) aqueous extract. Molecules 18, 5954–5964 (2013)CrossRef
86.
J. Dobson, Magnetic nanoparticles for drug delivery. Drug Dev. Res. 67, 55–60 (2006)CrossRef
87.
A. Ito, M. Kamihira, Tissue engineering using magnetite nanoparticles. Progr. Mol. Biol. Trans. Sci. 104, 355–395 (2010)CrossRef
88.
Š. Kubinová, E. Syková, Nanotechnologies in regenerative medicine. Minim. Invasive Ther. Allied Technol. 19, 144–156 (2010)CrossRef
89.
N. Bock, A. Riminucci, C. Dionigi, A. Russo, A. Tampieri, E. Landi, V.A. Goranov, M. Marcacci, V. Dediu, A novel route in bone tissue engineering: magnetic biomimetic scaffolds. Acta Biomater. 6, 786–796 (2010)CrossRef
90.
M. Ishii, R. Shibata, Y. Numaguchi, T. Kito, H. Suzuki, K. Shimizu, A. Ito, H. Honda, T. Murohara, Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method. Arterioscler. Thromb. Vasc. Biol. 31, 2210–2215 (2011)CrossRef
91.
M. Mahmoudi, M. Zhao, Y. Matsuura, S. Laurent, P.C. Yang, D. Bernstein, P. Ruiz-Lozano, V. Serpooshan, Infection-resistant MRI-visible scaffolds for tissue engineering applications. BioImpacts: BI 6, 111–115 (2016)
92.
V. Kandi, S. Kandi, Antimicrobial properties of nanomolecules: potential candidates as antibiotics in the era of multi-drug resistance. Epidemiol. Health 37, e2015020 (2015)CrossRef
93.
E.N. Taylor, K.M. Kummer, N.G. Durmus, K. Leuba, K.M. Tarquinio, T.J. Webster, Superparamagnetic Iron Oxide Nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms. Small 8, 3016–3027 (2012)CrossRef
94.
T. Sasaki, N. Iwasaki, K. Kohno, M. Kishimoto, T. Majima, S.I. Nishimura, A. Minami, Magnetic nanoparticles for improving cell invasion in tissue engineering. J. Biomed. Mater. Res., Part A 86, 969–978 (2008)CrossRef
95.
A. Ito, H. Akiyama, Y. Kawabe, M. Kamihira, Magnetic force-based cell patterning using Arg-Gly-Asp (RGD) peptide-conjugated magnetite cationic liposomes. J. Biosci. Bioeng. 104, 288–293 (2007)CrossRef
96.
A. Ito, Y. Takizawa, H. Honda, K.-I. Hata, H. Kagami, M. Ueda, T. Kobayashi, Tissue engineering using magnetite nanoparticles and magnetic force: heterotypic layers of cocultured hepatocytes and endothelial cells. Tissue Eng. 10, 833–840 (2004)CrossRef
97.
E.A. Lee, H. Yim, J. Heo, H. Kim, G. Jung, N.S. Hwang, Application of magnetic nanoparticle for controlled tissue assembly and tissue engineering. Arch. Pharmacal Res. 37, 120–128 (2014)CrossRef
98.
Y. Gao, J. Lim, S.-H. Teoh, C. Xu, Emerging translational research on magnetic nanoparticles for regenerative medicine. Chem. Soc. Rev. 44, 6306–6329 (2015)CrossRef
99.
G.R. Souza, J.R. Molina, R.M. Raphael, M.G. Ozawa, D.J. Stark, C.S. Levin, L.F. Bronk, J.S. Ananta, J. Mandelin, M.-M. Georgescu, Three-dimensional tissue culture based on magnetic cell levitation. Nat. Nanotechnol. 5, 291–296 (2010)CrossRef
100.
L.J. Santos, R.L. Reis, M.E. Gomes, Harnessing magnetic-mechano actuation in regenerative medicine and tissue engineering. Trends Biotechnol. 33, 471–479 (2015)CrossRef
101.
L. Borlido, A. Azevedo, A. Roque, M. Aires-Barros, Magnetic separations in biotechnology. Biotechnol. Adv. 31, 1374–1385 (2013)CrossRef
102.
I. Safarik, M. Safarikova, Magnetic techniques for the isolation and purification of proteins and peptides. BioMagn. Res. Technol. 2, 1–17 (2004)CrossRef
103.
P.A. Liberti, C.G. Rao, L.W. Terstappen, Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood. J. Magn. Magn. Mater. 225, 301–307 (2001)CrossRef
104.
Q.A. Pankhurst, J. Connolly, S.K. Jones, J. Dobson, Applications of magnetic nanoparticles in biomedicine. J. Phys. D Appl. Phys. 36, R167 (2003)CrossRef
105.
A.H. Latham, M.E. Williams, Controlling transport and chemical functionality of magnetic nanoparticles. Acc. Chem. Res. 41, 411–420 (2008)CrossRef
106.
K. Hola, Z. Markova, G. Zoppellaro, J. Tucek, R. Zboril, Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances. Biotechnol. Adv. 33, 1162–1176 (2015)CrossRef
107.
J. He, M. Huang, D. Wang, Z. Zhang, G. Li, Magnetic separation techniques in sample preparation for biological analysis: a review. J. Pharm. Biomed. Anal. 101, 84–101 (2014)CrossRef
108.
F. Wang, Y. Hu, C. Guo, W. Huang, C.-Z. Liu, Enhanced phenol degradation in coking wastewater by immobilized laccase on magnetic mesoporous silica nanoparticles in a magnetically stabilized fluidized bed. Bioresour. Technol. 110, 120–124 (2012)CrossRef
109.
M. Uyttendaele, I. Van Hoorde, J. Debevere, The use of immuno-magnetic separation (IMS) as a tool in a sample preparation method for direct detection of L. monocytogenes in cheese. Int. J. Food Microbiol. 54, 205–212 (2000)CrossRef
110.
J.R. Wisniewski, A. Zougman, N. Nagaraj, M. Mann, Universal sample preparation method for proteome analysis. Nat. Methods 6, 359–362 (2009)CrossRef
111.
M. Colombo, S. Carregal-Romero, M.F. Casula, L. Gutierrez, M.P. Morales, I.B. Boehm, J.T. Heverhagen, D. Prosperi, W.J. Parak, Biological applications of magnetic nanoparticles. Chem. Soc. Rev. 41, 4306–4334 (2012)CrossRef
112.
J.-C. Leroux, Injectable nanocarriers for biodetoxification. Nat. Nanotechnol. 2, 679–684 (2007)CrossRef
113.
M.D. Kaminski, A.J. Rosengart, Detoxification of blood using injectable magnetic nanospheres: a conceptual technology description. J. Magn. Magn. Mater. 293, 398–403 (2005)CrossRef
114.
M. Rahman, A.A. Saei, H. Amiri, M. Mahmoudi, Biomedical applications of superparamagnetic nanoparticles in molecular scale. Curr. Org. Chem. 19, 982–990 (2015)CrossRef
115.
L. Wang, Z. Yang, J. Gao, K. Xu, H. Gu, B. Zhang, X. Zhang, B. Xu, A biocompatible method of decorporation: bisphosphonate-modified magnetite nanoparticles to remove uranyl ions from blood. J. Am. Chem. Soc. 128, 13358–13359 (2006)CrossRef
116.
J.-J. Lee, K.J. Jeong, M. Hashimoto, A.H. Kwon, A. Rwei, S.A. Shankarappa, J.H. Tsui, D.S. Kohane, Synthetic ligand-coated magnetic nanoparticles for microfluidic bacterial separation from blood. Nano Lett. 14, 1–5 (2013)CrossRef
117.
H. Lee, T.J. Yoon, R. Weissleder, Ultrasensitive detection of bacteria using core-shell nanoparticles and an NMR-filter system. Angew. Chem. Int. Ed. 48, 5657–5660 (2009)CrossRef
118.
K. El-Boubbou, C. Gruden, X. Huang, Magnetic glyco-nanoparticles: a unique tool for rapid pathogen detection, decontamination, and strain differentiation. J. Am. Chem. Soc. 129, 13392–13393 (2007)CrossRef
119.
S. Ryan, A.J. Kell, H. van Faassen, L.-L. Tay, B. Simard, R. MacKenzie, M. Gilbert, J. Tanha, Single-domain antibody-nanoparticles: promising architectures for increased Staphylococcus aureus detection specificity and sensitivity. Biocon. Chem. 20, 1966–1974 (2009)CrossRef
120.
C. Kaittanis, S.A. Naser, J.M. Perez, One-step, nanoparticle-mediated bacterial detection with magnetic relaxation. Nano Lett. 7, 380–383 (2007)CrossRef
121.
S. Pal, E.C. Alocilja, Electrically active polyaniline coated magnetic (EAPM) nanoparticle as novel transducer in biosensor for detection of Bacillus anthracis spores in food samples. Biosens. Bioelectron. 24, 1437–1444 (2009)CrossRef
122.
J. Gao, H. Gu, B. Xu, Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc. Chem. Res. 42, 1097–1107 (2009)CrossRef
123.
H. Gu, K. Xu, C. Xu, B. Xu, Biofunctional magnetic nanoparticles for protein separation and pathogen detection. Chem. Commun. 9, 941–949 (2006)
124.
Q. Liu, J. Shi, M. Cheng, G. Li, D. Cao, G. Jiang, Preparation of graphene-encapsulated magnetic microspheres for protein/peptide enrichment and MALDI-TOF MS analysis. Chem. Commun. 48, 1874–1876 (2012)CrossRef
125.
H. Chen, D. Qi, C. Deng, P. Yang, X. Zhang, Preparation of C60-functionalized magnetic silica microspheres for the enrichment of low-concentration peptides and proteins for MALDI-TOF MS analysis. Proteomics 9, 380–387 (2009)CrossRef
126.
J.S. Kim, C.A. Valencia, R. Liu, W. Lin, Highly-efficient purification of native polyhistidine-tagged proteins by multivalent NTA-modified magnetic nanoparticles. Biocon. Chem. 18, 333–341 (2007)CrossRef
127.
S. Mazzucchelli, M. Colombo, C. De Palma, A. Salvade, P. Verderio, M.D. Coghi, E. Clementi, P. Tortora, F. Corsi, D. Prosperi, Single-domain protein A-engineered magnetic nanoparticles: toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells. ACS Nano 4, 5693–5702 (2010)CrossRef
128.
H. Cai, X. Gu, M.S. Scanlan, C.R. Lively, Development of a quantitative PCR assay for residual mouse DNA and comparison of four sample purification methods for DNA isolation. J. Pharm. Biomed. Anal. 55, 71–77 (2011)CrossRef
129.
D. Leung, S.O. Kang, E.V. Anslyn, Rapid determination of enantiomeric excess: a focus on optical approaches. Chem. Soc. Rev. 41, 448–479 (2012)CrossRef
130.
J.W. Hong, V. Studer, G. Hang, W.F. Anderson, S.R. Quake, A nanoliter-scale nucleic acid processor with parallel architecture. Nat. Biotechnol. 22, 435–439 (2004)CrossRef
131.
A. Soozanipour, A. Taheri-Kafrani, A.L. Isfahani, Covalent attachment of xylanase on functionalized magnetic nanoparticles and determination of its activity and stability. Chem. Eng. J. 270, 235–243 (2015)CrossRef
132.
K. Khoshnevisan, A.-K. Bordbar, D. Zare, D. Davoodi, M. Noruzi, M. Barkhi, M. Tabatabaei, Immobilization of cellulase enzyme on superparamagnetic nanoparticles and determination of its activity and stability. Chem. Eng. J. 171, 669–673 (2011)CrossRef
133.
M. Pečová, M. Šebela, Z. Markova, K. Polakova, J. Čuda, K. Šafářová, R. Zbořil, Thermostable trypsin conjugates immobilized to biogenic magnetite show a high operational stability and remarkable reusability for protein digestion. Nanotechnology 24, 125102 (2013)CrossRef
134.
C.-C. Yu, Y.-Y. Kuo, C.-F. Liang, W.-T. Chien, H.-T. Wu, T.-C. Chang, F.-D. Jan, C.-C. Lin, Site-specific immobilization of enzymes on magnetic nanoparticles and their use in organic synthesis. Biocon. Chem. 23, 714–724 (2012)CrossRef
135.
S. Metz, G. Bonaterra, M. Rudelius, M. Settles, E.J. Rummeny, H.E. Daldrup-Link, Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur. Radiol. 14, 1851–1858 (2004)CrossRef
136.
J.W. Bulte, Magnetic nanoparticles as markers for cellular MR imaging. J. Magn. Magn. Mater. 289, 423–427 (2005)CrossRef
137.
C. Zhang, T. Liu, J. Gao, Y. Su, C. Shi, Recent development and application of magnetic nanoparticles for cell labeling and imaging. Mini Rev. Med. Chem. 10, 194–203 (2010)CrossRef
138.
A.S. Arbab, G.T. Yocum, H. Kalish, E.K. Jordan, S.A. Anderson, A.Y. Khakoo, E.J. Read, J.A. Frank, Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104, 1217–1223 (2004)CrossRef
139.
J.W. Bulte, T. Douglas, B. Witwer, S.-C. Zhang, E. Strable, B.K. Lewis, H. Zywicke, B. Miller, P. van Gelderen, B.M. Moskowitz, Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 19, 1141–1147 (2001)CrossRef
140.
C.C. Berry, Progress in functionalization of magnetic nanoparticles for applications in biomedicine. J. Phys. D Appl. Phys. 42, 224003 (2009)CrossRef
141.
J.K. Herr, J.E. Smith, C.D. Medley, D. Shangguan, W. Tan, Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal. Chem. 78, 2918–2924 (2006)CrossRef
142.
J.E. Jaetao, K.S. Butler, N.L. Adolphi, D.M. Lovato, H.C. Bryant, I. Rabinowitz, S.S. Winter, T.E. Tessier, H.J. Hathaway, C. Bergemann, Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles. Cancer Res. 69, 8310–8316 (2009)CrossRef
143.
T. Kekarainen, S. Mannelin, J. Laine, T. Jaatinen, Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells. BMC Cell Biol. 7, 1–10 (2006)CrossRef
144.
K. Pantel, C. Alix-Panabières, S. Riethdorf, Cancer micrometastases. Nat. Rev. Clin. Oncol. 6, 339–351 (2009)CrossRef
145.
V.I. Shubayev, T.R. Pisanic, S. Jin, Magnetic nanoparticles for theragnostics. Adv. Drug Deliv. Rev. 61, 467–477 (2009)CrossRef
146.
X. Chen, S.T. Wong, Cancer theranostics: An introduction. Cancer Theranostics, Chap. 1, 3–8 (2014)CrossRef
147.
B.T. Luk, L. Zhang, Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis. ACS Appl. Mater. Interfaces 6, 21859–21873 (2014)CrossRef
148.
M. Zheng, S. Liu, J. Li, D. Qu, H. Zhao, X. Guan, X. Hu, Z. Xie, X. Jing, Z. Sun, Integrating oxaliplatin with highly luminescent carbon dots: an unprecedented theranostic agent for personalized medicine. Adv. Mater. 26, 3554–3560 (2014)CrossRef
149.
S.D. Jo, S.H. Ku, Y.-Y. Won, S.H. Kim, I.C. Kwon, Targeted nanotheranostics for future personalized medicine: recent progress in cancer therapy. Theranostics 6, 1362–1377 (2016)CrossRef
150.
J. Xie, S. Lee, X. Chen, Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev. 62, 1064–1079 (2010)CrossRef
151.
L.Y. Rizzo, B. Theek, G. Storm, F. Kiessling, T. Lammers, Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. Curr. Opin. Biotechnol. 24, 1159–1166 (2013)CrossRef
152.
T. Lammers, F. Kiessling, W.E. Hennink, G. Storm, Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol. Pharm. 7, 1899–1912 (2010)CrossRef
153.
A. Radomska, J. Leszczyszyn, M.W. Radomski, The nanopharmacology and nanotoxicology of nanomaterials: new opportunities and challenges. Adv. Clin. Exp. Med. Off. Organ Wroclaw Med. Univ. 25, 151 (2016)CrossRef
154.
S.M. Janib, A.S. Moses, J.A. MacKay, Imaging and drug delivery using theranostic nanoparticles. Adv. Drug Deliv. Rev. 62, 1052–1063 (2010)CrossRef
155.
B.T. Luk, R.H. Fang, L. Zhang, Lipid-and polymer-based nanostructures for cancer theranostics. Theranostics 2, 1117–1126 (2012)CrossRef
156.
M.S. Muthu, D.T. Leong, L. Mei, S.-S. Feng, Nanotheranostics-application and further development of nanomedicine strategies for advanced theranostics. Theranostics 4, 660–677 (2014)CrossRef
157.
T.H. Kim, S. Lee, X. Chen, Nanotheranostics for personalized medicine. Expert Rev. Mol. Diagn. 13, 257–269 (2013)CrossRef
158.
Z.-P. Liang, P.C. Lauterbur, Principles of Magnetic Resonance Imaging: A Signal Processing Perspective (The Institute of Electrical and Electronics Engineers Press, 2000)
159.
J. Hsieh, Computed Tomography: Principles, Design, Artifacts, and Recent Advances (SPIE Bellingham, WA, 2009)
160.
M.E. Phelps, Positron emission tomography provides molecular imaging of biological processes. Proc. Natl. Acad. Sci. 97, 9226–9233 (2000)CrossRef
161.
T.A. Holly, B.G. Abbott, M. Al-Mallah, D.A. Calnon, M.C. Cohen, F.P. DiFilippo, E.P. Ficaro, M.R. Freeman, R.C. Hendel, D. Jain, Single photon-emission computed tomography. J. Nucl. Cardiol. 17, 941–973 (2010)CrossRef
162.
C.R. Hill, J.C. Bamber, G. ter Haar, Physical Principles of Medical Ultrasonics (Wiley Online Library, 2004)
163.
M. Gu, Advanced Optical Imaging Theory (Springer Science & Business Media, 2000)
164.
G. Bao, S. Mitragotri, S. Tong, Multifunctional nanoparticles for drug delivery and molecular imaging. Annu. Rev. Biomed. Eng. 15, 253–282 (2013)CrossRef
165.
Y. Bao, T. Wen, A.C.S. Samia, A. Khandhar, K.M. Krishnan, Magnetic nanoparticles: material engineering and emerging applications in lithography and biomedicine. J. Mater. Sci. 51, 513–553 (2016)CrossRef
166.
N.A. Frey, S. Peng, K. Cheng, S. Sun, Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage. Chem. Soc. Rev. 38, 2532–2542 (2009)CrossRef
167.
T. Neuberger, B. Schöpf, H. Hofmann, M. Hofmann, B. Von Rechenberg, Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 293, 483–496 (2005)CrossRef
168.
M.F. Kircher, J.K. Willmann, Molecular body imaging: MR imaging, CT, and US. Part I. Principles. Radiology 263, 633–643 (2012)CrossRef
169.
J.K. Willmann, N. van Bruggen, L.M. Dinkelborg, S.S. Gambhir, Molecular imaging in drug development. Nat. Rev. Drug Discov. 7, 591–607 (2008)CrossRef
170.
N. Lee, T. Hyeon, Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem. Soc. Rev. 41, 2575–2589 (2012)CrossRef
171.
N. Lee, D. Yoo, D. Ling, M.H. Cho, T. Hyeon, J. Cheon, Iron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapy. Chem. Rev. 115, 10637–10689 (2015)CrossRef
172.
Z.R. Stephen, F.M. Kievit, M. Zhang, Magnetite nanoparticles for medical MR imaging. Mater. Today 14, 330–338 (2011)CrossRef
173.
P. Gatehouse, G. Bydder, Magnetic resonance imaging of short T2 components in tissue. Clin. Radiol. 58, 1–19 (2003)CrossRef
174.
M.M. Britton, Magnetic resonance imaging of chemistry. Chem. Soc. Rev. 39, 4036–4043 (2010)CrossRef
175.
P. Caravan, C.T. Farrar, L. Frullano, R. Uppal, Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium-and manganese-based T1 contrast agents. Contrast Media Mol. Imaging 4, 89–100 (2009)CrossRef
176.
Y.W. Jun, J.H. Lee, J. Cheon, Chemical design of nanoparticle probes for high‐performance magnetic resonance imaging. Angewandte Chemie International Edition, 47, 5122–5135 (2008)
177.
M.K. Uchiyama, S.H. Toma, S.F. de Paula Rodrigues, A.L.B. Shimada, R.A. Loiola, H.J.C. Rodríguez, P.V. Oliveira, M.S. Luz, S.R. Rabbani, H.E. Toma, Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool. Int. J. Nanomed. 10, 4731–4746 (2015)
178.
P. Reimer, T. Balzer, Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur. Radiol. 13, 1266–1276 (2003)
179.
J.R. McCarthy, R. Weissleder, Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Deliv. Rev. 60, 1241–1251 (2008)CrossRef
180.
M. Longmire, P.L. Choyke, H. Kobayashi, Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats (2008)
181.
E. Taboada, E. Rodríguez, A. Roig, J. Oró, A. Roch, R.N. Muller, Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging. Langmuir 23, 4583–4588 (2007)CrossRef
182.
M. Di Marco, C. Sadun, M. Port, I. Guilbert, P. Couvreur, C. Dubernet, Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. Int. J. Nanomed. 2, 609 (2007)
183.
D. Artemov, N. Mori, B. Okollie, Z.M. Bhujwalla, MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn. Reson. Med. 49, 403–408 (2003)CrossRef
184.
W. Wu, Z. Wu, T. Yu, C. Jiang, W.-S. Kim, Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications. Sci. Technol. Adv. Mater. 16, 023501 (2016)CrossRef
185.
J.M. Perez, L. Josephson, R. Weissleder, Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. ChemBioChem 5, 261–264 (2004)CrossRef
186.
R. Jin, B. Lin, D. Li, H. Ai, Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr. Opin. Pharmacol. 18, 18–27 (2014)CrossRef
187.
A. Neuwelt, N. Sidhu, C.-A.A. Hu, G. Mlady, S.C. Eberhardt, L.O. Sillerud, Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. AJR Am. J. Roentgenol. 204, W302–W313 (2015)CrossRef
188.
A. Millon, S. Dickson, A. Klink, D. Izquierdo-Garcia, J. Bini, E. Lancelot, S. Ballet, P. Robert, J.M. de Castro, C. Corot, Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and 18 F-FDG using a combined PET/MR scanner. Atherosclerosis 228, 339–345 (2013)CrossRef
189.
M.J. Jacobin-Valat, K. Deramchia, S. Mornet, C.E. Hagemeyer, S. Bonetto, R. Robert, M. Biran, P. Massot, S. Miraux, S. Sanchez, MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis. NMR Biomed. 24, 413–424 (2011)
190.
M.A. Busquets, R. Sabaté, J. Estelrich, Potential applications of magnetic particles to detect and treat Alzheimer’s disease. Nanoscale Res. Lett. 9, 1–10 (2014)CrossRef
191.
M.M. Vellinga, R.D.O. Engberink, A. Seewann, P.J. Pouwels, M.P. Wattjes, S.M. van der Pol, C. Pering, C.H. Polman, H.E. de Vries, J.J. Geurts, Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 131, 800–807 (2008)CrossRef
192.
J. Xie, K. Chen, J. Huang, S. Lee, J. Wang, J. Gao, X. Li, X. Chen, PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 31, 3016–3022 (2010)CrossRef
193.
O. Veiseh, C. Sun, J. Gunn, N. Kohler, P. Gabikian, D. Lee, N. Bhattarai, R. Ellenbogen, R. Sze, A. Hallahan, Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett. 5, 1003–1008 (2005)CrossRef
194.
H. Lee, M.K. Yu, S. Park, S. Moon, J.J. Min, Y.Y. Jeong, H.-W. Kang, S. Jon, Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. J. Am. Chem. Soc. 129, 12739–12745 (2007)CrossRef
195.
Y. Wang, X. Xie, X. Wang, G. Ku, K.L. Gill, D.P. O’Neal, G. Stoica, L.V. Wang, Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain. Nano Lett. 4, 1689–1692 (2004)CrossRef
196.
M.J. Welch, C.J. Hawker, K.L. Wooley, The advantages of nanoparticles for PET. J. Nucl. Med. 50, 1743–1746 (2009)CrossRef
197.
N. Lee, S.H. Choi, T. Hyeon, Nano-Sized CT Contrast Agents. Adv. Mater. 25, 2641–2660 (2013)CrossRef
198.
S. Narayanan, B.N. Sathy, U. Mony, M. Koyakutty, S.V. Nair, D. Menon, Biocompatible magnetite/gold nanohybrid contrast agents via green chemistry for MRI and CT bioimaging. ACS Appl. Mater. Interfaces 4, 251–260 (2011)CrossRef
199.
J. Liu, W. Zhang, H. Zhang, Z. Yang, T. Li, B. Wang, X. Huo, R. Wang, H. Chen, A multifunctional nanoprobe based on Au–Fe3O4 nanoparticles for multimodal and ultrasensitive detection of cancer cells. Chem. Commun. 49, 4938–4940 (2013)CrossRef
200.
Z. Liu, T. Lammers, J. Ehling, S. Fokong, J. Bornemann, F. Kiessling, J. Gätjens, Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 32, 6155–6163 (2011)CrossRef
201.
F. Kiessling, J. Huppert, M. Palmowski, Functional and molecular ultrasound imaging: concepts and contrast agents. Curr. Med. Chem. 16, 627–642 (2009)CrossRef
202.
R. Misra, S. Acharya, S.K. Sahoo, Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov. Today 15, 842–850 (2010)CrossRef
203.
U. Ikoba, H. Peng, H. Li, C. Miller, C. Yu, Q. Wang, Nanocarriers in therapy of infectious and inflammatory diseases. Nanoscale 7, 4291–4305 (2015)CrossRef
204.
O. Veiseh, B.C. Tang, K.A. Whitehead, D.G. Anderson, R. Langer, Managing diabetes with nanomedicine: challenges and opportunities. Nat. Rev. Drug Discov. 14, 45–57 (2015)CrossRef
205.
A.S. Gupta, Nanomedicine approaches in vascular disease: a review, Nanomedicine: Nanotechnology. Biol. Med. 7, 763–779 (2011)
206.
S. Roussakow, The history of hyperthermia rise and decline, in Conference Papers in Science, Hindawi Publishing Corporation, 2013 (2013) p. 428027
207.
O.S. Nielsen, M. Horsman, J. Overgaard, A future for hyperthermia in cancer treatment? Eur. J. Cancer 37, 1587–1589 (2001)CrossRef
208.
S. Mornet, S. Vasseur, F. Grasset, P. Veverka, G. Goglio, A. Demourgues, J. Portier, E. Pollert, E. Duguet, Magnetic nanoparticle design for medical applications. Prog. Solid State Chem. 34, 237–247 (2006)CrossRef
209.
P. Moroz, S. Jones, B. Gray, Magnetically mediated hyperthermia: current status and future directions. Int. J. Hyperth. 18, 267–284 (2002)CrossRef
210.
A. Jordan, R. Scholz, K. Maier-Hauff, M. Johannsen, P. Wust, J. Nadobny, H. Schirra, H. Schmidt, S. Deger, S. Loening, Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J. Magn. Magn. Mater. 225, 118–126 (2001)CrossRef
211.
A.E. Deatsch, B.A. Evans, Heating efficiency in magnetic nanoparticle hyperthermia. J. Magn. Magn. Mater. 354, 163–172 (2014)CrossRef
212.
C.S. Kumar, F. Mohammad, Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv. Drug Deliv. Rev. 63, 789–808 (2011)CrossRef
213.
M.F.X. Gnant, E.M. Turner, H.R. Alexander, Effects of hyperthermia and tumour necrosis factor on inflammatory cytokine secretion and procoagulant activity in endothelial cells. Cytokine 12, 339–347 (2000)CrossRef
214.
B. Hildebrandt, P. Wust, O. Ahlers, A. Dieing, G. Sreenivasa, T. Kerner, R. Felix, H. Riess, The cellular and molecular basis of hyperthermia. Critical Rev. Oncol./Hematol. 43, 33–56 (2002)CrossRef
215.
E. Kita, T. Oda, T. Kayano, S. Sato, M. Minagawa, H. Yanagihara, M. Kishimoto, C. Mitsumata, S. Hashimoto, K. Yamada, Ferromagnetic nanoparticles for magnetic hyperthermia and thermoablation therapy. J. Phys. D Appl. Phys. 43, 474011 (2010)CrossRef
216.
T.L. Kalber, K.L. Ordidge, P. Southern, M.R. Loebinger, P.G. Kyrtatos, Q.A. Pankhurst, M.F. Lythgoe, S.M. Janes, Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles. Int. J. Nanomed. 11, 1973–1983 (2016)CrossRef
217.
V.P. Torchilin, Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat. Rev. Drug Discov. 13, 813–827 (2014)CrossRef
218.
M. Hans, A. Lowman, Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater. Sci. 6, 319–327 (2002)CrossRef
219.
O.C. Farokhzad, R. Langer, Impact of nanotechnology on drug delivery. ACS Nano 3, 16–20 (2009)CrossRef
220.
S.S. Suri, H. Fenniri, B. Singh, Nanotechnology-based drug delivery systems. J. Occup. Med. Toxicol. 2, 1–6 (2007)CrossRef
221.
H. Maeda, J. Wu, T. Sawa, Y. Matsumura, K. Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Controlled Release 65, 271–284 (2000)CrossRef
222.
F. Danhier, O. Feron, V. Préat, To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Controlled Release 148, 135–146 (2010)CrossRef
223.
F. Chen, H. Hong, Y. Zhang, H.F. Valdovinos, S. Shi, G.S. Kwon, C.P. Theuer, T.E. Barnhart, W. Cai, In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. ACS Nano 7, 9027–9039 (2013)CrossRef
224.
O.C. Farokhzad, J. Cheng, B.A. Teply, I. Sherifi, S. Jon, P.W. Kantoff, J.P. Richie, R. Langer, Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. 103, 6315–6320 (2006)CrossRef
225.
M. Muthiah, I.-K. Park, C.-S. Cho, Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting. Biotechnol. Adv. 31, 1224–1236 (2013)CrossRef
226.
B. Chertok, B.A. Moffat, A.E. David, F. Yu, C. Bergemann, B.D. Ross, V.C. Yang, Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29, 487–496 (2008)CrossRef
227.
O. Veiseh, J.W. Gunn, M. Zhang, Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 62, 284–304 (2010)CrossRef
228.
A. Zarrin, S. Sadighian, K. Rostamizadeh, O. Firuzi, M. Hamidi, S. Mohammadi-Samani, R. Miri, Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy. Int. J. Pharm. 500, 62–76 (2016)CrossRef
229.
B. Polyak, G. Friedman, Magnetic targeting for site-specific drug delivery: applications and clinical potential. Expert Opin. Drug Deliv. 6, 53–70 (2009)CrossRef
230.
C. de las Heras Alarcón, S. Pennadam, C. Alexander, Stimuli responsive polymers for biomedical applications. Chem. Soc. Rev. 34, 276–285 (2005)
231.
J. Chomoucka, J. Drbohlavova, D. Huska, V. Adam, R. Kizek, J. Hubalek, Magnetic nanoparticles and targeted drug delivering. Pharmacol. Res. 62, 144–149 (2010)CrossRef
232.
M. Mikhaylova, D.K. Kim, N. Bobrysheva, M. Osmolowsky, V. Semenov, T. Tsakalakos, M. Muhammed, Superparamagnetism of magnetite nanoparticles: dependence on surface modification. Langmuir 20, 2472–2477 (2004)CrossRef
233.
S.K. Yen, P. Padmanabhan, S.T. Selvan, Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery. Theranostics 3, 986–1003 (2013)CrossRef
234.
L. Zhao, T. Chano, S. Morikawa, Y. Saito, A. Shiino, S. Shimizu, T. Maeda, T. Irie, S. Aonuma, H. Okabe, Hyperbranched polyglycerol-grafted superparamagnetic iron oxide nanoparticles: synthesis, characterization, functionalization, size separation, magnetic properties, and biological applications. Adv. Funct. Mater. 22, 5107–5117 (2012)CrossRef
235.
A.A. Moghanjoughi, D. Khoshnevis, A. Zarrabi, A concise review on smart polymers for controlled drug release. Drug Deliv. Transl. Res. 6, 333–340 (2016)CrossRef
236.
H. Mousavi, B. Movahedi, A. Zarrabi, M. Jahandar, A multifunctional hierarchically assembled magnetic nanostructure towards cancer nano-theranostics. RSC Adv. 5, 77255–77263 (2015)CrossRef
237.
N. Kamaly, A.D. Miller, Paramagnetic liposome nanoparticles for cellular and tumour imaging. Int. J. Mol. Sci. 11, 1759–1776 (2010)CrossRef
238.
N.G. Durmus, E.N. Taylor, K.M. Kummer, T.J. Webster, Enhanced efficacy of superparamagnetic iron oxide nanoparticles against antibiotic-resistant biofilms in the presence of metabolites. Adv. Mater. 25, 5706–5713 (2013)CrossRef
239.
J.H. Maeng, D.-H. Lee, K.H. Jung, Y.-H. Bae, I.-S. Park, S. Jeong, Y.-S. Jeon, C.-K. Shim, W. Kim, J. Kim, Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials 31, 4995–5006 (2010)CrossRef
240.
F.M. Kievit, F.Y. Wang, C. Fang, H. Mok, K. Wang, J.R. Silber, R.G. Ellenbogen, M. Zhang, Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro. J. Controlled Release 152, 76–83 (2011)CrossRef
241.
O. Mykhaylyk, Y.S. Antequera, D. Vlaskou, C. Plank, Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat. Protoc. 2, 2391–2411 (2007)CrossRef
242.
S. Govindarajan, K. Kitaura, M. Takafuji, H. Ihara, K. Varadarajan, A.B. Patel, V. Gopal, Gene delivery into human cancer cells by cationic lipid-mediated magnetofection. Int. J. Pharm. 446, 87–99 (2013)CrossRef
243.
U. Schillinger, T. Brill, C. Rudolph, S. Huth, S. Gersting, F. Krötz, J. Hirschberger, C. Bergemann, C. Plank, Advances in magnetofection—magnetically guided nucleic acid delivery. J. Magn. Magn. Mater. 293, 501–508 (2005)CrossRef
244.
P. Jendelová, V. Herynek, J. DeCroos, K. Glogarová, B. Andersson, M. Hájek, E. Syková, Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn. Reson. Med. 50, 767–776 (2003)CrossRef
245.
D.K. Kirui, D.A. Rey, C.A. Batt, Gold hybrid nanoparticles for targeted phototherapy and cancer imaging. Nanotechnology 21, 105105 (2010)CrossRef
246.
M. Chu, Y. Shao, J. Peng, X. Dai, H. Li, Q. Wu, D. Shi, Near-infrared laser light mediated cancer therapy by photothermal effect of Fe3O4 magnetic nanoparticles. Biomaterials 34, 4078–4088 (2013)CrossRef
247.
M. Thandu, V. Rapozzi, L. Xodo, F. Albericio, C. Comuzzi, S. Cavalli, “Clicking” porphyrins to magnetic nanoparticles for photodynamic therapy. ChemPlusChem 79, 90–98 (2014)CrossRef
248.
D.B. Tada, L.L. Vono, E.L. Duarte, R. Itri, P.K. Kiyohara, M.S. Baptista, L.M. Rossi, Methylene blue-containing silica-coated magnetic particles: a potential magnetic carrier for photodynamic therapy. Langmuir 23, 8194–8199 (2007)CrossRef
249.
A.E. Fard, A. Zarepour, A. Zarrabi, A. Shanei, H. Salehi, Synergistic effect of the combination of triethylene-glycol modified Fe3O4 nanoparticles and ultrasound wave on MCF-7 cells. J. Magn. Magn. Mater. 394, 44–49 (2015)CrossRef
250.
H. Xu, X. Zhang, R. Han, P. Yang, H. Ma, Y. Song, Z. Lu, W. Yin, X. Wu, H. Wang, Nanoparticles in sonodynamic therapy: state of the art review. RSC Advances 6, 50697–50705 (2016)CrossRef
251.
C. Tassa, S.Y. Shaw, R. Weissleder, Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc. Chem. Res. 44, 842–852 (2011)CrossRef
252.
H.-M. Yang, B.C. Oh, J.H. Kim, T. Ahn, H.-S. Nam, C.W. Park, J.-D. Kim, Multifunctional poly (aspartic acid) nanoparticles containing iron oxide nanocrystals and doxorubicin for simultaneous cancer diagnosis and therapy. Colloids Surf., A 391, 208–215 (2011)CrossRef
253.
H. Xu, L. Cheng, C. Wang, X. Ma, Y. Li, Z. Liu, Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery. Biomaterials 32, 9364–9373 (2011)CrossRef
254.
M. Jahandar, A. Zarrabi, M.A. Shokrgozar, H. Mousavi, Synthesis, characterization and application of polyglycerol coated Fe3O4 nanoparticles as a nano-theranostics agent. Mater. Res. Express 2, 125002 (2015)CrossRef
255.
N. Nasongkla, E. Bey, J. Ren, H. Ai, C. Khemtong, J.S. Guthi, S.-F. Chin, A.D. Sherry, D.A. Boothman, J. Gao, Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 6, 2427–2430 (2006)CrossRef
256.
H. Guo, W. Chen, X. Sun, Y.-N. Liu, J. Li, J. Wang, Theranostic magnetoliposomes coated by carboxymethyl dextran with controlled release by low-frequency alternating magnetic field. Carbohydr. Polym. 118, 209–217 (2015)CrossRef
257.
Q. Quan, J. Xie, H. Gao, M. Yang, F. Zhang, G. Liu, X. Lin, A. Wang, H.S. Eden, S. Lee, HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol. Pharm. 8, 1669–1676 (2011)CrossRef
258.
K. Cheng, S. Peng, C. Xu, S. Sun, Porous hollow Fe3O4 nanoparticles for targeted delivery and controlled release of cisplatin. J. Am. Chem. Soc. 131, 10637–10644 (2009)CrossRef
259.
C. Wang, S. Ravi, U.S. Garapati, M. Das, M. Howell, J. Mallela, S. Alwarappan, S.S. Mohapatra, S. Mohapatra, Multifunctional chitosan magnetic-graphene (CMG) nanoparticles: a theranostic platform for tumor-targeted co-delivery of drugs, genes and MRI contrast agents. J. Mater. Chem. B 1, 4396–4405 (2013)CrossRef
260.
H. Yang, Y. Li, T. Li, M. Xu, Y. Chen, C. Wu, X. Dang, Y. Liu, Multifunctional core/shell nanoparticles cross-linked polyetherimide-folic acid as efficient Notch-1 siRNA carrier for targeted killing of breast cancer. Sci. Rep. 4, 7072 (2014)CrossRef
261.
M.K. Jaiswal, M. De, S.S. Chou, S. Vasavada, R. Bleher, P.V. Prasad, D. Bahadur, V.P. Dravid, Thermoresponsive magnetic hydrogels as theranostic nanoconstructs. ACS Appl. Mater. Interfaces 6, 6237–6247 (2014)CrossRef
262.
M.M. Yallapu, S.F. Othman, E.T. Curtis, B.K. Gupta, M. Jaggi, S.C. Chauhan, Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials 32, 1890–1905 (2011)CrossRef
263.
G.R. Reddy, M.S. Bhojani, P. McConville, J. Moody, B.A. Moffat, D.E. Hall, G. Kim, Y.-E.L. Koo, M.J. Woolliscroft, J.V. Sugai, Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin. Cancer Res. 12, 6677–6686 (2006)CrossRef
264.
K. Yang, L. Hu, X. Ma, S. Ye, L. Cheng, X. Shi, C. Li, Y. Li, Z. Liu, Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv. Mater. 24, 1868–1872 (2012)CrossRef
265.
Z. Zhou, Y. Sun, J. Shen, J. Wei, C. Yu, B. Kong, W. Liu, H. Yang, S. Yang, W. Wang, Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy. Biomaterials 35, 7470–7478 (2014)CrossRef
266.
L. Cheng, K. Yang, Y. Li, X. Zeng, M. Shao, S.-T. Lee, Z. Liu, Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 33, 2215–2222 (2012)CrossRef
267.
W. Dong, Y. Li, D. Niu, Z. Ma, J. Gu, Y. Chen, W. Zhao, X. Liu, C. Liu, J. Shi, Facile synthesis of monodisperse superparamagnetic Fe3O4 core@hybrid@Au shell nanocomposite for bimodal imaging and photothermal therapy. Adv. Mater. 23, 5392–5397 (2011)CrossRef
268.
H.-Y. Huang, S.-H. Hu, S.-Y. Hung, C.-S. Chiang, H.-L. Liu, T.-L. Chiu, H.-Y. Lai, Y.-Y. Chen, S.-Y. Chen, SPIO nanoparticle-stabilized PAA-F127 thermosensitive nanobubbles with MR/US dual-modality imaging and HIFU-triggered drug release for magnetically guided in vivo tumor therapy. J. Controlled Release 172, 118–127 (2013)CrossRef
269.
J. Huang, M. Guo, H. Ke, C. Zong, B. Ren, G. Liu, H. Shen, Y. Ma, X. Wang, H. Zhang, Rational Design and Synthesis of γFe2O3@Au Magnetic Gold Nanoflowers for Efficient Cancer Theranostics. Adv. Mater. 27, 5049–5056 (2015)CrossRef
270.
D. Calle, V. Negri, P. Ballesteros, S. Cerdán, Magnetoliposomes loaded with poly-unsaturated fatty acids as novel theranostic anti-inflammatory formulations. Theranostics (2015)
271.
T. Fu, Q. Kong, H. Sheng, L. Gao, Value of functionalized superparamagnetic iron oxide nanoparticles in the diagnosis and treatment of acute temporal lobe epilepsy on MRI. Neural Plast. 2016, 2412958 (2016)
272.
L. Moraes, A. Vasconcelos-dos-Santos, F.C. Santana, M.A. Godoy, P.H. Rosado-de-Castro, R.L. Azevedo-Pereira, W.M. Cintra, E.L. Gasparetto, M.F. Santiago, R. Mendez-Otero, Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington’s disease. Stem Cell Res. 9, 143–155 (2012)CrossRef
273.
P. Wang, M.V. Yigit, Z. Medarova, L. Wei, G. Dai, C. Schuetz, A. Moore, Combined small interfering RNA therapy and in vivo magnetic resonance imaging in islet transplantation. Diabetes 60, 565–571 (2011)CrossRef
274.
N. Ahmed, H. Fessi, A. Elaissari, Theranostic applications of nanoparticles in cancer. Drug Discov. Today 17, 928–934 (2012)CrossRef
275.
C. von Zur, D.Von Muhlen, N. Elverfeldt, I. Bassler, B. Neudorfer, A. Steitz, H. Petri-Fink, C. Hofmann, K. Bode, Peter, Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis 193, 102–111 (2007)CrossRef
276.
M. Lundqvist, J. Stigler, G. Elia, I. Lynch, T. Cedervall, K.A. Dawson, Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. 105, 14265–14270 (2008)CrossRef
277.
A. Lesniak, A. Salvati, M.J. Santos-Martinez, M.W. Radomski, K.A. Dawson, C. Åberg, Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J. Am. Chem. Soc. 135, 1438–1444 (2013)CrossRef
278.
A.K. Gupta, M. Gupta, Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26, 1565–1573 (2005)CrossRef
279.
L.L. Muldoon, M. Sàndor, K.E. Pinkston, E.A. Neuwelt, Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery 57, 785–796 (2005)CrossRef
280.
M. Mahmoudi, A. Simchi, A. Milani, P. Stroeve, Cell toxicity of superparamagnetic iron oxide nanoparticles. J. Colloid Interface Sci. 336, 510–518 (2009)CrossRef
281.
F. Dilnawaz, S.K. Sahoo, Therapeutic approaches of magnetic nanoparticles for the central nervous system. Drug Discovery Today 20, 1256–1264 (2015)CrossRef
282.
G. Huang, H. Chen, Y. Dong, X. Luo, H. Yu, Z. Moore, E.A. Bey, D.A. Boothman, J. Gao, Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics 3, 116–126 (2013)CrossRef
283.
L. Zeng, Z. Shen, A. Wu, Magnetic nanomaterials for tumor targeting theranostics. Nanomater. Tumor Targ. Theranostics: A Proact. Clin. Perspect. (2016) 55
Metadata
Title
SPIONs as Nano-Theranostics Agents
Authors
Atefeh Zarepour
Ali Zarrabi
Arezoo Khosravi
Copyright Year
2017
Publisher
Springer Singapore
Book
SPIONs as Nano-Theranostics Agents

Print ISBN: 978-981-10-3562-3

Electronic ISBN: 978-981-10-3563-0

Copyright Year: 2017

DOI
https://doi.org/10.1007/978-981-10-3563-0_1